COMMUNIQUÉS West-GlobeNewswire

Trevi Therapeutics to Participate in Upcoming September Conferences
03/09/2026
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting
03/09/2026
- Data support the ongoing development of four investigational therapies for DMD amenable to skipping of exons 53, 45, 44 or 55, all of which are advancing into IND-enabling studies - - All development candidates [...]
TG Therapeutics to Participate in the Cantor Global Healthcare Conference
03/09/2026
Fireside chat scheduled for Wednesday, September 9, 2026, at 11:30am ET NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and [...]
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
03/09/2026
MELBOURNE, Australia and SAN FRANCISCO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
03/09/2026
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Recognition in the [...]
Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality
03/09/2026
Feature Explores the Real Biology Behind Recombinant Spider Silk and the Scientific Case for Kraig Labs' Production Platform ANN ARBOR, Mich., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2026
NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of [...]
Nu-Tek BioSciences’ Animal-Free Raw Materials Drive Cell Culture Media Evolution, Supply Security at CPHI Global 2026 in Milan
03/09/2026
Nu-Tek will engage pharmaceutical stakeholders at CPHI Global, Oct. 6-8 in Milan, to discuss its 100% animal-free peptones and protein hydrolysates that support cell culture media qualification while strengthening [...]
Ingredient Testing Doesn't Predict a Finished Joint Supplement's Results
03/09/2026
Glucosamine and chondroitin have been studied for decades, producing small and inconsistent pain-relief results across systematic reviews. Cartigenix HP® with RestorCel® has been evaluated as a complete formulation [...]
Nu-Tek au salon CPHI Global 2026 à Milan : les matières premières sans composants d’origine animale de Nu-Tek BioSciences favorisent l’évolution des milieux de culture cellulaire et la sécurité d’approvisionnement
03/09/2026
Nu-Tek viendra à la rencontre des acteurs du secteur pharmaceutique lors du salon CPHI Global, qui se tiendra du 6 au 8 octobre à Milan, afin de présenter ses peptones et hydrolysats de protéines 100 % sans composants d [...]
Oligonucleotide Drug Delivery Is Moving Beyond the Liver
03/09/2026
Beyond-liver delivery is becoming the next major frontier for oligonucleotide medicines, with growing efforts to reach muscle, the central nervous system, lung, immune cells and tumors. No single delivery technology is [...]
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc. (Nasdaq: BLSM), a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative [...]
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
MILAN, Italy and MORRISTOWN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for [...]
Avalo Therapeutics to Participate in Upcoming Investor Conferences
03/09/2026
WAYNE, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated [...]
Cartesian Therapeutics to Participate in Upcoming Investor Conferences
03/09/2026
FREDERICK, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today [...]
Breckenridge Distillery and Southern Glazer’s Expand Partnership Across New York and California
03/09/2026
Strategic Distribution Expansion Accelerates Growth for Breckenridge Distillery in Two of the Largest Spirits Markets in the U.S. Expanded Partnership Also Supports Rapid Growth of Breckenridge Distillery’s Ready-to- [...]
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
03/09/2026
TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of [...]
Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
03/09/2026
~29-day half-life Single 320 mg dose of CLYM116 drove near-complete APRIL suppression and 60-75% IgA/Gd-IgA1 suppression through 12 weeks CLYM116 generally well-tolerated, with no serious adverse events, dose-limiting [...]
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
03/09/2026
BOTHELL, Wash., Sept. 03, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs [...]

Pages